Summary:
A redesigned cancer immunotherapy is showing striking early results after decades of disappointment with similar drugs. Researchers engineered a more powerful CD40 agonist antibody and changed how it’s delivered—injecting it directly into tumors instead of into the bloodstream. In a small clinical trial of 12 patients with metastatic cancers, six saw their tumors shrink and two experienced complete remission.
This is also a good example for the crowd who don’t think progress is being made. Curing mice of cancer eventually flows though to human lives saved.
We’ve made huge progress in cancer treatment in my lifetime. I hope to see it more or less cured in the time I have left.